bis(4-[1-(4-chlorophenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine);1-(4-chlorophenyl)-3-(oxan-4-ylmethyl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxolan-3-yl)imidazo[1,5-a]pyrazine;4-[1-(4-methylphenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine

C83H80Cl4N18O5 — CID 158264190

IUPACbis(4-[1-(4-chlorophenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine);1-(4-chlorophenyl)-3-(oxan-4-ylmethyl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxolan-3-yl)imidazo[1,5-a]pyrazine;4-[1-(4-methylphenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine
SMILESCc1ccc(-c2nc(N3CCOCC3)n3ccncc23)cc1.Clc1ccc(-c2nc(C3CCOC3)n3ccncc23)cc1.Clc1ccc(-c2nc(CC3CCOCC3)n3ccncc23)cc1.Clc1ccc(-c2nc(N3CCOCC3)n3ccncc23)cc1.Clc1ccc(-c2nc(N3CCOCC3)n3ccncc23)cc1
InChIInChI=1S/C18H18ClN3O.C17H18N4O.2C16H15ClN4O.C16H14ClN3O/c19-15-3-1-14(2-4-15)18-16-12-20-7-8-22(16)17(21-18)11-13-5-9-23-10-6-13;1-13-2-4-14(5-3-13)16-15-12-18-6-7-21(15)17(19-16)20-8-10-22-11-9-20;2*17-13-3-1-12(2-4-13)15-14-11-18-5-6-21(14)16(19-15)20-7-9-22-10-8-20;17-13-3-1-11(2-4-13)15-14-9-18-6-7-20(14)16(19-15)12-5-8-21-10-12/h1-4,7-8,12-13H,5-6,9-11H2;2-7,12H,8-11H2,1H3;2*1-6,11H,7-10H2;1-4,6-7,9,12H,5,8,10H2
InChIKeyGIFSKUAIYHRQLT-UHFFFAOYSA-N
MW1551.49 g/mol
LogP15.89
Rot. Bonds11

About bis(4-[1-(4-chlorophenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine);1-(4-chlorophenyl)-3-(oxan-4-ylmethyl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxolan-3-yl)imidazo[1,5-a]pyrazine;4-[1-(4-methylphenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine

bis(4-[1-(4-chlorophenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine);1-(4-chlorophenyl)-3-(oxan-4-ylmethyl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxolan-3-yl)imidazo[1,5-a]pyrazine;4-[1-(4-methylphenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine (PubChem CID 158264190) has the molecular formula C83H80Cl4N18O5 and a molecular weight of 1551.49 g/mol. Its IUPAC name is bis(4-[1-(4-chlorophenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine);1-(4-chlorophenyl)-3-(oxan-4-ylmethyl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxolan-3-yl)imidazo[1,5-a]pyrazine;4-[1-(4-methylphenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine.

Molecular Properties

Compound Namebis(4-[1-(4-chlorophenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine);1-(4-chlorophenyl)-3-(oxan-4-ylmethyl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxolan-3-yl)imidazo[1,5-a]pyrazine;4-[1-(4-methylphenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine
PubChem CID158264190
Molecular FormulaC83H80Cl4N18O5
Molecular Weight1551.49 g/mol
Exact Mass1548.53
IUPAC Namebis(4-[1-(4-chlorophenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine);1-(4-chlorophenyl)-3-(oxan-4-ylmethyl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxolan-3-yl)imidazo[1,5-a]pyrazine;4-[1-(4-methylphenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine
SMILESCc1ccc(-c2nc(N3CCOCC3)n3ccncc23)cc1.Clc1ccc(-c2nc(C3CCOC3)n3ccncc23)cc1.Clc1ccc(-c2nc(CC3CCOCC3)n3ccncc23)cc1.Clc1ccc(-c2nc(N3CCOCC3)n3ccncc23)cc1.Clc1ccc(-c2nc(N3CCOCC3)n3ccncc23)cc1
InChIInChI=1S/C18H18ClN3O.C17H18N4O.2C16H15ClN4O.C16H14ClN3O/c19-15-3-1-14(2-4-15)18-16-12-20-7-8-22(16)17(21-18)11-13-5-9-23-10-6-13;1-13-2-4-14(5-3-13)16-15-12-18-6-7-21(15)17(19-16)20-8-10-22-11-9-20;2*17-13-3-1-12(2-4-13)15-14-11-18-5-6-21(14)16(19-15)20-7-9-22-10-8-20;17-13-3-1-11(2-4-13)15-14-9-18-6-7-20(14)16(19-15)12-5-8-21-10-12/h1-4,7-8,12-13H,5-6,9-11H2;2-7,12H,8-11H2,1H3;2*1-6,11H,7-10H2;1-4,6-7,9,12H,5,8,10H2
InChIKeyGIFSKUAIYHRQLT-UHFFFAOYSA-N
XLogP15.89
TPSA206.82 Ų
H-Bond Donors
H-Bond Acceptors23
Rotatable Bonds11
Heavy Atoms110
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001551.49
LogP ≤ 515.89
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1023

Analyze bis(4-[1-(4-chlorophenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine);1-(4-chlorophenyl)-3-(oxan-4-ylmethyl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxolan-3-yl)imidazo[1,5-a]pyrazine;4-[1-(4-methylphenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of bis(4-[1-(4-chlorophenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine);1-(4-chlorophenyl)-3-(oxan-4-ylmethyl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxolan-3-yl)imidazo[1,5-a]pyrazine;4-[1-(4-methylphenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine?
The IUPAC name of bis(4-[1-(4-chlorophenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine);1-(4-chlorophenyl)-3-(oxan-4-ylmethyl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxolan-3-yl)imidazo[1,5-a]pyrazine;4-[1-(4-methylphenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine (CID 158264190) is bis(4-[1-(4-chlorophenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine);1-(4-chlorophenyl)-3-(oxan-4-ylmethyl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxolan-3-yl)imidazo[1,5-a]pyrazine;4-[1-(4-methylphenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine.
What is the SMILES notation for bis(4-[1-(4-chlorophenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine);1-(4-chlorophenyl)-3-(oxan-4-ylmethyl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxolan-3-yl)imidazo[1,5-a]pyrazine;4-[1-(4-methylphenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine?
The canonical SMILES for bis(4-[1-(4-chlorophenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine);1-(4-chlorophenyl)-3-(oxan-4-ylmethyl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxolan-3-yl)imidazo[1,5-a]pyrazine;4-[1-(4-methylphenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine is Cc1ccc(-c2nc(N3CCOCC3)n3ccncc23)cc1.Clc1ccc(-c2nc(C3CCOC3)n3ccncc23)cc1.Clc1ccc(-c2nc(CC3CCOCC3)n3ccncc23)cc1.Clc1ccc(-c2nc(N3CCOCC3)n3ccncc23)cc1.Clc1ccc(-c2nc(N3CCOCC3)n3ccncc23)cc1.
What is the InChIKey of bis(4-[1-(4-chlorophenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine);1-(4-chlorophenyl)-3-(oxan-4-ylmethyl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxolan-3-yl)imidazo[1,5-a]pyrazine;4-[1-(4-methylphenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine?
The InChIKey is GIFSKUAIYHRQLT-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H18ClN3O.C17H18N4O.2C16H15ClN4O.C16H14ClN3O/c19-15-3-1-14(2-4-15)18-16-12-20-7-8-22(16)17(21-18)11-13-5-9-23-10-6-13;1-13-2-4-14(5-3-13)16-15-12-18-6-7-21(15)17(19-16)20-8-10-22-11-9-20;2*17-13-3-1-12(2-4-13)15-14-11-18-5-6-21(14)16(19-15)20-7-9-22-10-8-20;17-13-3-1-11(2-4-13)15-14-9-18-6-7-20(14)16(19-15)12-5-8-21-10-12/h1-4,7-8,12-13H,5-6,9-11H2;2-7,12H,8-11H2,1H3;2*1-6,11H,7-10H2;1-4,6-7,9,12H,5,8,10H2.
What are the key properties of bis(4-[1-(4-chlorophenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine);1-(4-chlorophenyl)-3-(oxan-4-ylmethyl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxolan-3-yl)imidazo[1,5-a]pyrazine;4-[1-(4-methylphenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine?
bis(4-[1-(4-chlorophenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine);1-(4-chlorophenyl)-3-(oxan-4-ylmethyl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxolan-3-yl)imidazo[1,5-a]pyrazine;4-[1-(4-methylphenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine has a molecular weight of 1551.49 g/mol, XLogP of 15.89, 11 rotatable bonds, 0 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for bis(4-[1-(4-chlorophenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine);1-(4-chlorophenyl)-3-(oxan-4-ylmethyl)imidazo[1,5-a]pyrazine;1-(4-chlorophenyl)-3-(oxolan-3-yl)imidazo[1,5-a]pyrazine;4-[1-(4-methylphenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine is sourced from PubChem (CID 158264190), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).